5-aminosalicylic acid as a maintenance therapy for ulcerative colitis:an analysis of 114 cases

Ji Shen,Jun-Xia Li,Hua-Hong Wang,Yi-Xuan Li,Yu Tian,Xin-Guang Liu
2011-01-01
World Chinese Journal of Digestology
Abstract:AIM:To evaluate the clinical significance of 5-aminosalicylic acid(5-ASA) as a maintenance therapy for patients with ulcerative colitis(UC).METHODS:The clinical data for 114 UC patients(including 64 males and 50 females,aged from 16 to 76 years old) treated from January 2004 to August 2010 were analyzed retrospectively.RESULTS:Seventy-f ive patients(65.8%) underwent 5-ASA therapy for induction of remission.There was no correlation between sex and the relapse rate of UC.The relapse rate in patients who had a history of more than 5 years was higher than those with a shorter history(62.1% vs 35.7%,P > 0.05).The relapse rate was significantly lower in mild patients undergoing maintenance treatment with 5-ASA more than 2 g daily than in those given 5-ASA less than 2 g daily(10% vs 33.3%,P < 0.05),in patients with mild disease than in those with moderate or severe disease(24.6% vs 83.3%,80.6%,both P< 0.05),in patients with proctitis than in those without proctitis(P < 0.05),and in patients who achieved mucosal healing than in those who did not(4.8% vs 89.6%,P < 0.05).The relapse rate of UC gradually increased from the second year after remission.CONCLUSION:Mucosal healing and disease activity of UC are the most important factors associated with the recurrence of the disease.5-ASA is the first choice for patients with mild and moderate disease.UC patients undergoing maintenance treatment with 5-ASA more than 2 g daily for 2 years can reduce the recurrence of the disease.
What problem does this paper attempt to address?